ABMC in his bio
JOHN J. MORONEY
FOUNDER AND PRESIDENT
Mr. Moroney is the Founder and President of Landmark Pegasus, Inc., and a seasoned business leader in both the Life Science and Healthcare industries, with extensive experience in corporate strategy, business development, finance and operational management.
Landmark was founded in 1983 and focused initially on development stage life science companies, with a special emphasis on generic drug companies. Among its early clients was Par Pharmaceutical (ENDO) , Sidmak Laboratories, Copley Pharmaceutical, Barr Laboratories, Zenith Pharmaceutical — now all part of TEVA.
Prior to founding Landmark, Mr. Moroney spent 10 years in commercial banking with Citibank, United Jersey Bank and Midlantic Banks, where he gained extensive experience in commercial lending and the use of the Economic Development Agency programs to fund emerging companies both in New Jersey and New York State.
Between 1985 and 1991 Landmark operated under an exclusive arrangement with Ladenburg Thalmann & Co., Inc., one of the oldest investment banks in New York, with Mr. Moroney serving as Managing Director of their Life Science group. During this period, Landmark served as investment banker to many noted Life Science companies, including the IPOs of Par Pharmaceutical, Alfin Fragrances, and Physicians Computer Network, Landmark also advised Columbia Laboratories on their IPO and their first product acquisition.
Landmark was also retained to restructure and finance Carrington Laboratories and MacroChem Laboratories. Mr. Moroney advised on Copley Pharmaceutical’s restructuring and subsequent private placement of equity and served as a director of the company until the sale of that interest to TA Associates. Landmark also introduced and advised F. Faulding & Co.Ltd., (Australia’s largest pharmaceutical company) on the acquisition of Solvay’s Purepac division.
In 1991, Ladenburg Thalmann underwent a change of ownership and management, and their exclusive arrangement with Landmark ended on amicable terms. While affiliated with Ladenburg, Mr. Moroney developed a unique service niche specializing in assisting foreign clients to become established in the US, and developing various strategies for U.S. market penetration. Landmark implemented a very successful strategy of cross border merger and acquisitions, licensing and joint ventures for their clients.
Through these assignments, Landmark has gained the trust and respect of our clients and they have experienced greater access to the capital markets which in turn has resulted in higher valuations and greater liquidity for them. During Landmark’s long history of servicing and advising clients in the healthcare arena, the Company has developed a vast network of both domestic and international industry relationships. Landmark’s clients have included Elan Pharmaceuticals, Fresenius, Ethypharm, Serono, Altana AG, Dynamit Nobel, and Drug Royalty Corp.
Starting in 1991, Landmark expanded their services to include the Nutrition industry, which today represents a large percentage of the company’s business. Clients have includes Nutrition21, Rexall Sundown, Balchem, Glanbia, Twin Labs (LBO) and a 25 year relationship with Pharmachem Laboratories, one of the largest branded ingredient manufacturer’s in the U.S. Medical Foods clients have included Medifast, Inc. (MED) and Pam Labs (Nestle).
Landmark continued their restructuring practice working with many companies like IGI Labs (Teligent – TLGT), Precision Optics, Inc (PEYE), American Bio Medica Corporation (ABMC), and Materials Processing Technology, Inc.
Mr. Moroney is also an experienced entrepreneur and investor, having active interests in pharmaceuticals, nutritionals, diagnostics and medical device companies. He was the co-founder of Flemington Pharmaceuticals, where he served for 10 years in various capacities including Chairman and CEO. He presided over the Company’s IPO and follow-on financings. He divested his holdings in 2003 with the completion of a financing to Paramount Capital. He was also the co-founder of Juvent Inc., a medical device company, Compliant Rx Solutions, Inc., a pharmaceutical services company, MD Diagnostics, and Dermworx Inc. Additionally, he served from 2010 to 2014 as the Chairman of Bedminster Financial Group Ltd., a licensed broker-dealer and member of FINRA, SIPIC and MSRB.
Mr. Moroney holds a B.S. and M.B.A. from Fordham University, and is a member of the Licensing Executives Society and the American Chemical Society.
AI
